Skip to NavigationSkip to content

Pharmafile - Medical Communications

FDA grant orphan drug designation to XMT-2056 for treatment of gastric cancer
Mersana Theapeutics has announced that the FDA has granted orphan drug designation to XMT-2056, the company’s lead Immunosynthen STING-agonist ADC,...
WHO says world still unprepared for future pandemics even after COVID-19
An expert panel has said that the world is still not ready for future pandemics, despite having years to prepare for COVID-19.
Collaboration to boost access to cancer medicines in low- and middle-income countries
Novartis, Roche, and other pharmaceutical companies have formed a coalition with global cancer organisations in an aim to get more oncology...
ANGLE technology could alter how prostate cancer is treated
Researchers from Barts Cancer Institute will use ANGLE’s new technology, Parsortix, to isolate and assess circulating tumour cells as a predictor of...
>> More Medical Communications News Stories

Features

Outsourcing in clinical trials: A response to rising challenges

Clinical trials are complex, multifaceted projects, and this makes them infamously expensive to run, but outsourcing to contract research...

>> More Features

Appointments

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a wealth of experience across...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches